Peptide questions · Rapamycin
Rapamycin side effects: what studies and users report
Reviewed Evidence: EmergingPublished by PepVault
The side effects most commonly reported for rapamycin are mouth sores (stomatitis), higher cholesterol and triglycerides and slower wound healing, among 5 the library lists; the library’s evidence on it includes controlled trials in people.
Its safety note opens: A prescription drug.
What is commonly reported with rapamycin
- Mouth sores (stomatitis)
- Higher cholesterol and triglycerides
- Slower wound healing
- Diarrhea or nausea
- Acne
Common here means the library lists it among the effects people most often report; the list doesn’t say how often each one happens.
| Effect | Also listed for (of 37) |
|---|---|
| Mouth sores (stomatitis) | None: listed for Rapamycin alone |
| Higher cholesterol and triglycerides | None: listed for Rapamycin alone |
| Slower wound healing | None: listed for Rapamycin alone |
| Diarrhea or nausea | None: listed for Rapamycin alone |
| Acne | 1: DHEA |

Which rapamycin side effects the longevity group shares
Across the 38 longevity compounds in the library, the effects listed most often are usually none above placebo in the trials (4 of 38), acne (2 of 38), not well characterised in people yet (2 of 38) and rare liver injury (supplement-associated) (2 of 38). Rapamycin shares 1 of its 5 listed effects with at least one other longevity compound; mouth sores (stomatitis), higher cholesterol and triglycerides, slower wound healing and diarrhea or nausea are listed for rapamycin alone.
What the rapamycin safety notes say
The library’s safety note
A prescription drug. Its FDA label (as sirolimus) is for preventing kidney-transplant rejection and for lymphangioleiomyomatosis, at daily doses of 2–5 mg adjusted to blood levels, and carries a boxed warning: immunosuppression can raise the risk of infection, lymphoma and other cancers. The label also names impaired wound healing, fluid build-up, raised cholesterol and triglycerides, raised blood sugar, and lung inflammation (pneumonitis), rare but serious. Weekly low-dose use for aging is off-label: in the 48-week PEARL trial, adverse events at 5 or 10 mg a week were similar to placebo. Live vaccines are avoided while taking it, per the label. Discuss with your clinician, who can check lipids, glucose and blood counts.
The library’s interaction note
Sirolimus is broken down by CYP3A4 and P-gp, so strong inhibitors (ketoconazole, itraconazole, voriconazole, clarithromycin, erythromycin) raise its levels and strong inducers (rifampin) lower them; the label says to avoid both, and not to take it with grapefruit juice. Vaccines may work less well, and live vaccines are avoided. Discuss every medication with your clinician.
These are reference notes from published research and reported use, not advice for a person: discuss your own situation with your clinician.
Where the rapamycin reports come from
The library rates the evidence on rapamycin as emerging: mostly preclinical, with limited human data.
Of the library’s 5 research notes on rapamycin, 1 rest on randomized trials, 2 on clinical data and 2 on animal studies.
So rapamycin has controlled trials in people to set its listed effects against.
Questions people ask
What are the side effects of rapamycin?
The side effects most commonly reported for rapamycin are mouth sores (stomatitis), higher cholesterol and triglycerides and slower wound healing, among 5 the library lists; the library’s evidence on it includes controlled trials in people.
Do rapamycin’s side effects come from human studies?
The library rates the evidence on rapamycin as emerging, and the library’s evidence on it includes controlled trials in people.
Which rapamycin side effects are its own?
Among the longevity compounds, the library lists mouth sores (stomatitis), higher cholesterol and triglycerides, slower wound healing and diarrhea or nausea for rapamycin alone.
Does rapamycin interact with other medicines?
The library’s interaction note on rapamycin begins: Sirolimus is broken down by CYP3A4 and P-gp, so strong inhibitors (ketoconazole, itraconazole, voriconazole, clarithromycin, erythromycin) raise its levels and strong inducers (rifampin) lower them; the label says to avoid both, and not to take it with grapefruit juice.